Discover how Trump’s healthcare picks could reshape U.S. biopharma and drive major changes in the healthcare policy.

Discover various promising treatments in development to address the unmet needs of people with Charcot–Marie–Tooth disease.

Delve into the field of miRNA with 7 promising companies with miRNA-focused candidates in the pipeline, from oncology to ...

Discover how ADCs are advancing oncology, the regulatory challenges they face, and the promise they hold for the future of ...

Antisense oligonucleotides are essentially short, single-stranded synthetic fragments of DNA or RNA that bind specifically to the target RNA sequence inside cells and modulate protein expression ...

It’s fair to say Evotec has been part of the European biotech landscape for quite some time. Indeed, it was founded in 1993 in Hamburg, Germany, and stands out as a rare breed: part service provider, ...